Evidence map›Paper›PMID 41957010›Full record

ArticleNPJ genomic medicine2026

Unraveling the genetic architecture of non-Huntington chorea: a biobank-scale study of rare variants and repeat expansions.

Fulya Akçimen, Monica Diez-Fairen, Ignacio Alvarez, Victor Puente, Spencer Grant, Jorge Hernandez-Vara, Marzieh Khani, Mariateresa Buongiorno, Félix Javier Jiménez-Jiménez, José A G Agúndez and 17 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Fulya AkçimenLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Monica Diez-FairenGenomcore, Barcelona, Spain.
Ignacio AlvarezDepartment of Neuroscience, Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
Victor PuenteMovement Disorders Unit, Neurology, Hospital del Mar, Barcelona, Spain.
Spencer GrantLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Jorge Hernandez-VaraMovement Disorders Unit, Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Marzieh KhaniCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Mariateresa BuongiornoMovement Disorders Unit, Neurology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.
José A G AgúndezUniversidad de Extremadura, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.
Miquel AguilarMovement Disorders Unit, Neurology, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain.
Esther CuboHospital Universitario Burgos and Health Science Department, University of Burgos, Burgos, Spain.
Jesus PerezMovement Disorders Unit, Neurology, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Javier PagonabarragaMovement Disorders Unit, Neurology, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Núria CaballolNeurology, Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Asuncion AvilaNeurology, Complex Hospitalari Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
Jinhui DingLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Elena García-MartínUniversidad de Extremadura, University Institute of Molecular Pathology Biomarkers, Cáceres, Spain.
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.
Yaroslau ComptaParkinson's Disease and Movement Disorders Unit, Neurology, Hospital Clínic Universitari de Barcelona / UBNeuro / IDIBAPS, Barcelona, Catalonia, Spain.
Carlos CruchagaDepartment of Psychiatry, Neurogenomics and Informatics, Department of Neurology, Hope Center for Neurologic Diseases, Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
Katrin BeyerDepartment of Neuroscience, Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
J Raphael GibbsLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Andrew SingletonLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Sara Bandres-Ciga *Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. sara.bandresciga@nih.gov.
Pau Pastor *Department of Neuroscience, Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain. pastorpau@gmail.com.
Spanish Study Group for Genetics of Chorea members

Funding

National Institutes of Health, Department of Health and Human Services ZO1 AG000535
6 · The paper itself

Abstract

Chorea can arise from genetic, metabolic, pharmacologic, and autoimmune causes. In clinical practice, however, non-genetic causes are rare. The most common genetic cause is a CAG repeat expansion in HTT, leading to Huntington's disease (HD). Beyond HD, systematic studies have been lacking and many individuals with non-HD chorea remain without a molecular diagnosis. We conducted whole-exome and genome sequencing analysis on 190 non-HD chorea cases, leveraging data from the All of Us Research Program (n = 134), UK Biobank (n = 26), and a clinically ascertained multicenter Spanish cohort recruited by the Spanish Study Group for Genetics of Chorea (SSGGC) (n = 30). Variant calling was performed without pre-filtering based on a disease or gene list, and variants were clinically contextualized using OMIM, ClinVar, and in silico predictions. We identified thirteen protein-altering variants, including six previously described as pathogenic or likely pathogenic. Notably, we identified a pathogenic JPH3 expansion in a patient of Black race and c9orf72 expansions in individuals of European and South Asian ancestry. These findings explained 23% of cases in the SSGGC, 12% in UK Biobank, and 4% in All of Us. Our results broaden the genetic architecture of non-HD chorea and highlight the value of multi-ancestry genomic approaches for rare movement disorders.

Identifiers

PMID41957010
PMCPMC13243629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.